27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The Schedule
The 58th Annual Meeting of the organization, scheduled for December 3 to 6, is held in San Diego.The first meeting was held in the Atlantic City, New Jersey in April 1958.
For those interested in the event, the full schedule can be located here.
The ASH Annual Meeting comes ahead of the JPMorgan 35th Annual 2017 Healthcare Conference scheduled to be held between January 9 and 12, 2017, in San Francisco.
The Importance
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Meetings and conferences such as these, which are attended by a number of healthcare professionals and investors, present a platform for biotech and healthcare companies to showcase their pipeline, efficacy and safety profiles and the potential of their treatment candidates and issue guidance for the coming year.
Some of the biotech stocks, historically and consistently, generate positive returns around the conference. A report carried by CNBC based on Kensho showed that Dynavax Technologies Corporation (NASDAQ: DVAX), Exelixis, Inc. (NASDAQ: EXEL) and Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) previously generated returns in excess of 70 percent in the first five days after the start of the ASH Annual Meeting. Thus, these meetings provide a significant trading opportunity.
Just as there is potential for meaningful upside, there are also chances of these stocks being dumped, if key catalytic events do not meet investor expectations.
ASH Annual Meeting 2016
The ASH Annual Meeting of 2016 focuses on the latest clinical, basic and translational research related to hematologic, malignancies and benign blood disorders. About 5,000 scientific abstracts were scheduled to be presented over the four-day event.
Some of the anticipated presentations this year include:
- Practice-changing results in chronic lymphocytic leukemia, or CLL.
- New results with CAR T cell therapy.
- Large trial of transplants in Myeloma.
- A new agent for sickle cell disease.
Companies, which derive a chunk of their revenues from hematology include:
- Acceleron Pharma Inc (NASDAQ: XLRN).
- Agios Pharmaceuticals Inc (NASDAQ: AGIO).
- Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN).
- Amgen, Inc. (NASDAQ: AMGN).
- bluebird bio Inc (NASDAQ: BLUE).
- Celgene Corporation (NASDAQ: CELG).
- Incyte Corporation (NASDAQ: INCY).
- Kite Pharma Inc (NASDAQ: KITE).
- Seattle Genetics, Inc. (NASDAQ: SGEN).
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.